Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptium Oncology was a leading healthcare services company that specialized in the development and management of outpatient cancer centers. Originally founded as Salick Health Care and later becoming a subsidiary of AstraZeneca, the company partnered with prominent hospital systems to establish integrated, multidisciplinary cancer programs. Their service offerings included clinical research management, facility operations, and strategic consulting tailored to oncology care. In 2012, the company was acquired by McKesson Corporation and integrated into its Specialty Health division and the US Oncology Network. Aptium was recognized for its "hospital-within-a-hospital" model, which aimed to streamline patient care and improve clinical outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aptium Oncology.